Raymond James Financial’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.75M Buy
97,573
+10,907
+13% +$531K ﹤0.01% 2409
2025
Q1
$2.95M Buy
86,666
+4,571
+6% +$156K ﹤0.01% 2699
2024
Q4
$3.23M Buy
+82,095
New +$3.23M ﹤0.01% 2612